argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
814.94
+20.34 (2.56%)
At close: Feb 12, 2026
argenx SE Market Cap
argenx SE has a market cap or net worth of $45.56 billion as of March 10, 2026. Its market cap has increased by 17.85% in one year.
Market Cap
45.56B
Enterprise Value
41.20B
Revenue
4.25B
Ranking
n/a
PE Ratio
35.26
Stock Price
$814.94
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 166.50M to 45.56B, an increase of 27,260.47%. That is a compound annual growth rate of 61.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 44.74B | -13.14% |
| Dec 31, 2025 | 51.51B | 37.35% |
| Dec 31, 2024 | 37.50B | 67.18% |
| Dec 29, 2023 | 22.43B | 8.92% |
| Dec 30, 2022 | 20.59B | 11.15% |
| Dec 31, 2021 | 18.53B | 32.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 366.07M |
| CytoDyn | 298.03M |
| Silence Therapeutics | 292.38M |
| Vaxart | 184.89M |
| BioStem Technologies | 86.47M |
| HST Global | 70.72M |
| Nuo Therapeutics | 60.36M |
| Vicapsys Life Sciences | 48.56M |